We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Volunteering as an Intervention to Reduce Depression Among Adolescents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03816215
Recruitment Status : Completed
First Posted : January 25, 2019
Last Update Posted : March 2, 2021
Sponsor:
Information provided by (Responsible Party):
Wake Forest University Health Sciences

Brief Summary:
The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism.

Condition or disease Intervention/treatment Phase
Depression Adolescent Behavior Depressive Symptoms Behavioral: Volunteer experience Not Applicable

Detailed Description:
The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism. In addition, this study will test a potential mechanism by which volunteering might decrease depressive symptoms: increasing psychosocial assets, specifically decreasing self-orientation and increasing an orientation toward others. This will be measured through self-report as well as using functional magnetic resonance imaging (fMRI). This study will be the first study to explore how neural response patterns are potentially altered by intense experiences with volunteerism among depressed adolescents.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 9 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Volunteering as an Intervention to Reduce Depression Among Adolescents: Investigating Neurobiological Mechanisms
Actual Study Start Date : June 3, 2019
Actual Primary Completion Date : August 1, 2020
Actual Study Completion Date : August 1, 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Adolescent Participants
Participants will be assigned to participate in community service (from a menu of options) for 30 hours.
Behavioral: Volunteer experience
Participants will be assigned to a meaningful volunteer experience from a menu of local options (e.g., volunteering at an animal shelter or in a library) for 30 hours.




Primary Outcome Measures :
  1. Participant recruitment [ Time Frame: 6 months ]
    Number of participants screened (reported by clinical mental health providers)

  2. Participant retention [ Time Frame: 6 months ]
    Number of participants retained in full study

  3. Depressive symptoms (Beck Depression Inventory) [ Time Frame: 6 months ]
    Beck Depression Inventory to measure depressive symptoms. Each item is rated on a 4-point scale ranging from 0 to 3. The minimum total score is 0 and the maximum total score is 63. Higher scores denote worse outcome


Secondary Outcome Measures :
  1. Strength of Connectivity in DMN (Default Mode Network) [ Time Frame: 6 months ]
    Default Mode Network Connectivity will be measured using fMRI at rest and while processing emotional pictures before and after volunteering intervention. The strength of connectivity within the DMN will be calculated by averaging attributes for each node in the DMN.

  2. Hope scale (Abler et al., 2017) [ Time Frame: 6 months ]
    Hope scale (Abler et al., 2017) will be measured on a scale from 1 (strongly disagree) to 5 (strongly agree). Items will be averaged; higher scores denote better outcome (more hope).

  3. Beck Hopelessness Inventory [ Time Frame: 6 months ]
    Beck Hopelessness Inventory will be used (scored from 1-20; higher score denotes worse outcome).

  4. Self-efficacy [ Time Frame: 6 months ]
    NIH toolbox measure from 1 (never) to 5 (very often); scores will be averaged and high score indicates more self-efficacy.

  5. Orientation Toward Others [ Time Frame: 6 months ]
    5 point scale from 1=strongly disagree to 5=strongly agree. Scores will be averaged; higher score denotes more orientation toward others.

  6. Empathy [ Time Frame: 6 months ]
    IRI (Interpersonal Reactivity Index) subscale to measure empathy on a 5 point scale from 1- strongly disagree to 5 -strongly agree. Scores will be averaged; higher score denotes more empathy.


Other Outcome Measures:
  1. Experience in Volunteering [ Time Frame: 6 months ]
    Measured through the Inventory of Service Experience (Taylor & Pancer, 2007) on a scale from 1 (strongly disagree) to 5 (strongly agree). Scores will be averaged for subscales of the measure. Higher score denotes better outcomes (more positive experiences with volunteering).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 20 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 14-20
  • new mild to moderate depression diagnosis (single episode)
  • new mild to moderate anxiety diagnosis
  • new adjustment disorder diagnosis
  • have been in treatment for < 8 months
  • right-handed

Exclusion Criteria:

  • history of recurrent depressive, anxiety or adjustment disorder episodes
  • have been in treatment > 8 months
  • left-handed
  • expressing suicidal ideation
  • claustrophobia
  • any contraindications for completing an MRI scan

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03816215


Locations
Layout table for location information
United States, North Carolina
Trinity Center, Inc
Winston-Salem, North Carolina, United States, 27101
TriCare, PA
Winston-Salem, North Carolina, United States, 27103
Private practice
Winston-Salem, North Carolina, United States, 27106
Sponsors and Collaborators
Wake Forest University Health Sciences
Investigators
Layout table for investigator information
Principal Investigator: Parissa Ballard, PhD Wake Forest University Health Sciences
  Study Documents (Full-Text)

Documents provided by Wake Forest University Health Sciences:
Informed Consent Form  [PDF] June 12, 2020

Publications:
Layout table for additonal information
Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT03816215    
Other Study ID Numbers: IRB00053435
First Posted: January 25, 2019    Key Record Dates
Last Update Posted: March 2, 2021
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Wake Forest University Health Sciences:
Adolescents
FMRI
volunteerism
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders